McKesson Corporation (MCK)
NYSE: MCK · IEX Real-Time Price · USD
584.83
-1.51 (-0.26%)
Jul 2, 2024, 4:00 PM EDT - Market closed

McKesson Revenue

In the fiscal year ending March 31, 2024, McKesson had annual revenue of $308.95B with 11.65% growth. Revenue in the quarter ending March 31, 2024 was $76.36B with 10.80% year-over-year growth.

Revenue (ttm)
$308.95B
Revenue Growth
+11.65%
P/S Ratio
0.25
Revenue / Employee
$6,057,863
Employees
51,000
Market Cap
75.86B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024308.95B32.24B11.65%
Mar 31, 2023276.71B12.75B4.83%
Mar 31, 2022263.97B25.74B10.80%
Mar 31, 2021238.23B7.18B3.11%
Mar 31, 2020231.05B16.73B7.81%
Mar 31, 2019214.32B5.96B2.86%
Mar 31, 2018208.36B9.82B4.95%
Mar 31, 2017198.53B7.65B4.01%
Mar 31, 2016190.88B11.84B6.61%
Mar 31, 2015179.05B41.65B30.32%
Mar 31, 2014137.39B15.20B12.44%
Mar 31, 2013122.20B-125.00M-0.10%
Mar 31, 2012122.32B10.24B9.13%
Mar 31, 2011112.08B3.38B3.11%
Mar 31, 2010108.70B2.07B1.94%
Mar 31, 2009106.63B4.93B4.85%
Mar 31, 2008101.70B8.73B9.39%
Mar 31, 200792.98B5.99B6.89%
Mar 31, 200686.98B7.89B9.97%
Mar 31, 200579.10B9.89B14.28%
Mar 31, 200469.21B12.09B21.16%
Mar 31, 200357.12B7.13B14.27%
Mar 31, 200249.99B7.99B19.02%
Mar 31, 200142.00B5.29B14.42%
Mar 31, 200036.71B6.74B22.48%
Mar 31, 199929.97B7.87B35.58%
Mar 31, 199822.11B5.19B30.69%
Mar 31, 199716.91B3.95B30.46%
Mar 31, 199612.96B3.53B37.36%
Mar 31, 19959.44B917.90M10.77%
Mar 31, 19948.52B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CVS Health 360.94B
Humana 109.24B
HCA Healthcare 66.72B
Bristol-Myers Squibb Company 45.53B
GSK 39.41B
Gilead Sciences 27.45B
Becton, Dickinson and Company 19.72B
Zoetis 8.73B
Revenue Rankings